Lingohr & Partner Asset Management GmbH »

Halozyme Therapeutics shares owned by Lingohr & Partner Asset Management GmbH

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Lingohr & Partner Asset Management GmbH from 13F filings

Historical chart of Lingohr & Partner Asset Management GmbH investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Lingohr & Partner Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Lingohr & Partner Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2025-09-30 $211k 2.9k 73.19